Estimating the burden of SARS-CoV-2 in France
Open accessPublished version of a preprint
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
COVID-19 pandemic in France: Coronavirus disease 2019 (COVID-19) exacted a heavy toll in France during March and April 2020. Quarantine measures were effective in reducing transmission by 84%, and some relaxation of social isolation was expected in May. Salje et al. fit transmission models for the epidemic in France to hospital admissions. The authors forecast that 2.9 million people will have been infected by 11 May, representing 4.4% of the population—a value inadequate for herd immunity. Daily critical care hospitalizations should reduce from several hundreds to tens of cases, but control will remain a delicate balancing act. Any relaxation of lockdown in France will have to be carefully controlled and monitored to avoid undermining more optimistic forecasts. Science , this issue p. 208
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several studies have estimated cumulative infections in select countries at specific points in time.6, 7, 8, 9”
From Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis (2022) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gelman, A., Carlin, J. B., Stern, H. S., & Rubin, D. B. (2003) · doi:10.1201/9780429258480 · Cited by 27,276
Diekmann, O., Heesterbeek, J. A. P., & Metz, J. A. J. (1990) · Journal of Mathematical Biology · doi:10.1007/bf00178324 · Cited by 5,091
Yang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., Guo, Q., Ji, R., Wang, H., Wang, Y., & Zhou, Y. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.017 · Cited by 4,206
Estimates of the severity of coronavirus disease 2019: a model-based analysis
Verity, R., Okell, L. C., Dorigatti, I., Winskill, P., Whittaker, C., Imai, N., Cuomo-Dannenburg, G., Thompson, H., Walker, P. G. T., Fu, H., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30243-7 · Cited by 3,660
The effect of human mobility and control measures on the COVID-19 epidemic in China
Kraemer, M. U. G., Yang, C.-H., Gutierrez, B., Wu, C.-H., Klein, B., Pigott, D. M., Open COVID-19 Data Working Group, du Plessis, L., Faria, N. R., Li, R., et al. (2020) · Science · doi:10.1126/science.abb4218 · Cited by 2,950
Mizumoto, K., Kagaya, K., Zarebski, A., & Chowell, G. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.10.2000180 · Cited by 2,276
Tian, H., Liu, Y., Li, Y., Wu, C.-H., Chen, B., Kraemer, M. U. G., Li, B., Cai, J., Xu, B., Yang, Q., et al. (2020) · Science · doi:10.1126/science.abb6105 · Cited by 2,010
Bi, Q., Wu, Y., Mei, S., Ye, C., Zou, X., Zhang, Z., Liu, X., Wei, L., Truelove, S. A., Zhang, T., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30287-5 · Cited by 1,958
Self-citationLinton, N., Kobayashi, T., Yang, Y., Hayashi, K., Akhmetzhanov, A., Jung, S.-M., Yuan, B., Kinoshita, R., & Nishiura, H. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020538 · Cited by 1,361
How generation intervals shape the relationship between growth rates and reproductive numbers
Wallinga, J., & Lipsitch, M. (2007) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2006.3754 · Cited by 1,213
Cited by
Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe
Flaxman, S., Mishra, S., Gandy, A., Unwin, H. J. T., Mellan, T. A., Coupland, H., Whittaker, C., Zhu, H., Berah, T., Eaton, J. W., et al. (2020) · Nature · doi:10.1038/s41586-020-2405-7 · Cited by 3,350
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Hadjadj, J., Yatim, N., Barnabei, L., Corneau, A., Boussier, J., Smith, N., Péré, H., Charbit, B., Bondet, V., Chenevier-Gobeaux, C., et al. (2020) · Science · doi:10.1126/science.abc6027 · Cited by 2,984
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., et al. (2021) · Science · doi:10.1126/science.abg3055 · Cited by 2,581
Pollán, M., Pérez-Gómez, B., Pastor-Barriuso, R., Oteo, J., Hernán, M. A., Pérez-Olmeda, M., Sanmartín, J. L., Fernández-García, A., Cruz, I., Fernández de Larrea, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31483-5 · Cited by 1,639
Age-specific mortality and immunity patterns of SARS-CoV-2
O’Driscoll, M., Ribeiro Dos Santos, G., Wang, L., Cummings, D. A. T., Azman, A. S., Paireau, J., Fontanet, A., Cauchemez, S., & Salje, H. (2021) · Nature · doi:10.1038/s41586-020-2918-0 · Cited by 1,210
Self-citationCOVID-19 and diabetes mellitus: from pathophysiology to clinical management
Lim, S., Bae, J. H., Kwon, H.-S., & Nauck, M. A. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00435-4 · Cited by 1,006
Aging in COVID-19: Vulnerability, immunity and intervention
Chen, Y., Klein, S. L., Garibaldi, B. T., Li, H., Wu, C., Osevala, N. M., Li, T., Margolick, J. B., Pawelec, G., & Leng, S. X. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101205 · Cited by 1,007
Walker, P. G. T., Whittaker, C., Watson, O. J., Baguelin, M., Winskill, P., Hamlet, A., Djafaara, B. A., Cucunubá, Z., Olivera Mesa, D., Green, W., et al. (2020) · Science · doi:10.1126/science.abc0035 · Cited by 993
The Macroeconomics of Epidemics
Eichenbaum, M., Rebelo, S., & Trabandt, M. (2020) · National Bureau of Economic Research · doi:10.3386/w26882 · Cited by 873
Karagiannidis, C., Mostert, C., Hentschker, C., Voshaar, T., Malzahn, J., Schillinger, G., Klauber, J., Janssens, U., Marx, G., Weber-Carstens, S., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30316-7 · Cited by 785
Schwarzinger, M., Watson, V., Arwidson, P., Alla, F., & Luchini, S. (2021) · The Lancet Public Health · doi:10.1016/s2468-2667(21)00012-8 · Cited by 778
Model-informed COVID-19 vaccine prioritization strategies by age and serostatus
Bubar, K. M., Reinholt, K., Kissler, S. M., Lipsitch, M., Cobey, S., Grad, Y. H., & Larremore, D. B. (2021) · Science · doi:10.1126/science.abe6959 · Cited by 775
Britton, T., Ball, F., & Trapman, P. (2020) · Science · doi:10.1126/science.abc6810 · Cited by 645
Reduction in mobility and COVID-19 transmission
Nouvellet, P., Bhatia, S., Cori, A., Ainslie, K. E. C., Baguelin, M., Bhatt, S., Boonyasiri, A., Brazeau, N. F., Cattarino, L., Cooper, L. V., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21358-2 · Cited by 581
Meyerowitz-Katz, G., & Merone, L. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.09.1464 · Cited by 566
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., et al. (2020) · doi:10.1101/2020.12.24.20248822 · Cited by 2,557
COVID-19 herd immunity: where are we?
Fontanet, A., & Cauchemez, S. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-00451-5 · Cited by 537
Self-citationNon-pharmaceutical interventions during the COVID-19 pandemic: A review
Perra, N. (2021) · Physics Reports · doi:10.1016/j.physrep.2021.02.001 · Cited by 531
The Macroeconomics of Epidemics
Eichenbaum, M. S., Rebelo, S., & Trabandt, M. (2021) · The Review of Financial Studies · doi:10.1093/rfs/hhab040 · Cited by 517
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
Huo, J., Le Bas, A., Ruza, R. R., Duyvesteyn, H. M. E., Mikolajek, H., Malinauskas, T., Tan, T. K., Rijal, P., Dumoux, M., Ward, P. N., et al. (2020) · Nature Structural & Molecular Biology · doi:10.1038/s41594-020-0469-6 · Cited by 500
Epidemiology and transmission dynamics of COVID-19 in two Indian states
Laxminarayan, R., Wahl, B., Dudala, S. R., Gopal, K., Mohan B, C., Neelima, S., Jawahar Reddy, K. S., Radhakrishnan, J., & Lewnard, J. A. (2020) · Science · doi:10.1126/science.abd7672 · Cited by 485
Russell, T. W., Hellewell, J., Jarvis, C. I., van Zandvoort, K., Abbott, S., Ratnayake, R., CMMID COVID-19 working group, Flasche, S., Eggo, R. M., Edmunds, W. J., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.12.2000256 · Cited by 464
Louapre, C., Collongues, N., Stankoff, B., Giannesini, C., Papeix, C., Bensa, C., Deschamps, R., Créange, A., Wahab, A., Pelletier, J., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.2581 · Cited by 455
Lai, A. G., Pasea, L., Banerjee, A., Hall, G., Denaxas, S., Chang, W. H., Katsoulis, M., Williams, B., Pillay, D., Noursadeghi, M., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-043828 · Cited by 447
Monk, P. D., Marsden, R. J., Tear, V. J., Brookes, J., Batten, T. N., Mankowski, M., Gabbay, F. J., Davies, D. E., Holgate, S. T., Ho, L.-P., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30511-7 · Cited by 438
The emergence, genomic diversity and global spread of SARS-CoV-2
Li, J., Lai, S., Gao, G. F., & Shi, W. (2021) · Nature · doi:10.1038/s41586-021-04188-6 · Cited by 413
Impact of lockdown on COVID-19 epidemic in Île-de-France and possible exit strategies
Di Domenico, L., Pullano, G., Sabbatini, C. E., Boëlle, P.-Y., & Colizza, V. (2020) · BMC Medicine · doi:10.1186/s12916-020-01698-4 · Cited by 396
Impacts of COVID-19 on Global Supply Chains: Facts and Perspectives
Xu, Z., Elomri, A., Kerbache, L., & El Omri, A. (2020) · IEEE Engineering Management Review · doi:10.1109/emr.2020.3018420 · Cited by 396
Immune ageing at single-cell resolution
Mogilenko, D. A., Shchukina, I., & Artyomov, M. N. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00646-4 · Cited by 381
Differential effects of intervention timing on COVID-19 spread in the United States
(2020) · doi:10.1126/sciadv.abd6370 · Cited by 366
The global impact of the coronavirus pandemic
Hiscott, J., Alexandridi, M., Muscolini, M., Tassone, E., Palermo, E., Soultsioti, M., & Zevini, A. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.010 · Cited by 355
Substantial underestimation of SARS-CoV-2 infection in the United States
Wu, S. L., Mertens, A. N., Crider, Y. S., Nguyen, A., Pokpongkiat, N. N., Djajadi, S., Seth, A., Hsiang, M. S., Colford, J. M., Reingold, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18272-4 · Cited by 355
COVID-19 impacts on child and youth anxiety and depression: challenges and opportunities
Courtney, D., Watson, P., Battaglia, M., Mulsant, B. H., & Szatmari, P. (2020) · The Canadian Journal of Psychiatry · doi:10.1177/0706743720935646 · Cited by 354
A stochastic agent-based model of the SARS-CoV-2 epidemic in France
Hoertel, N., Blachier, M., Blanco, C., Olfson, M., Massetti, M., Rico, M. S., Limosin, F., & Leleu, H. (2020) · Nature Medicine · doi:10.1038/s41591-020-1001-6 · Cited by 352
Years of life lost to COVID-19 in 81 countries
Pifarré i Arolas, H., Acosta, E., López-Casasnovas, G., Lo, A., Nicodemo, C., Riffe, T., & Myrskylä, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-83040-3 · Cited by 312
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden
Rudberg, A.-S., Havervall, S., Månberg, A., Jernbom Falk, A., Aguilera, K., Ng, H., Gabrielsson, L., Salomonsson, A.-C., Hanke, L., Murrell, B., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18848-0 · Cited by 303
Barber, R. M., Sorensen, R. J. D., Pigott, D. M., Bisignano, C., Carter, A., Amlag, J. O., Collins, J. K., Abbafati, C., Adolph, C., Allorant, A., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00484-6 · Cited by 298
Nishiura, H., Kobayashi, T., Yang, Y., Hayashi, K., Miyama, T., Kinoshita, R., Linton, N., Jung, S.-M., Yuan, B., Suzuki, A., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020419 · Cited by 286
The total number and mass of SARS-CoV-2 virions
Sender, R., Bar-On, Y. M., Gleizer, S., Bernshtein, B., Flamholz, A., Phillips, R., & Milo, R. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2024815118 · Cited by 275
Two distinct immunopathological profiles in autopsy lungs of COVID-19
Nienhold, R., Ciani, Y., Koelzer, V. H., Tzankov, A., Haslbauer, J. D., Menter, T., Schwab, N., Henkel, M., Frank, A., Zsikla, V., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18854-2 · Cited by 246
Fontanet, A., Tondeur, L., Grant, R., Temmam, S., Madec, Y., Bigot, T., Grzelak, L., Cailleau, I., Besombes, C., Ungeheuer, M.-N., et al. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.15.2001695 · Cited by 264
Self-citationOptimal Mitigation Policies in a Pandemic: Social Distancing and Working from Home
Jones, C., Philippon, T., & Venkateswaran, V. (2020) · National Bureau of Economic Research · doi:10.3386/w26984 · Cited by 243
Underdetection of cases of COVID-19 in France threatens epidemic control
Pullano, G., Di Domenico, L., Sabbatini, C. E., Valdano, E., Turbelin, C., Debin, M., Guerrisi, C., Kengne-Kuetche, C., Souty, C., Hanslik, T., et al. (2021) · Nature · doi:10.1038/s41586-020-03095-6 · Cited by 253
Mental health of French students during the Covid-19 pandemic
Essadek, A., & Rabeyron, T. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.08.042 · Cited by 249
Sharma, M., Mindermann, S., Rogers-Smith, C., Leech, G., Snodin, B., Ahuja, J., Sandbrink, J. B., Monrad, J. T., Altman, G., Dhaliwal, G., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26013-4 · Cited by 231
Popa, A., Genger, J.-W., Nicholson, M. D., Penz, T., Schmid, D., Aberle, S. W., Agerer, B., Lercher, A., Endler, L., Colaço, H., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abe2555 · Cited by 217
Salzberger, B., Buder, F., Lampl, B., Ehrenstein, B., Hitzenbichler, F., Holzmann, T., Schmidt, B., & Hanses, F. (2021) · Infection · doi:10.1007/s15010-020-01531-3 · Cited by 216
Optimal Mitigation Policies in a Pandemic: Social Distancing and Working from Home
Jones, C., Philippon, T., & Venkateswaran, V. (2021) · The Review of Financial Studies · doi:10.1093/rfs/hhab076 · Cited by 214
Lewnard, J. A., Liu, V. X., Jackson, M. L., Schmidt, M. A., Jewell, B. L., Flores, J. P., Jentz, C., Northrup, G. R., Mahmud, A., Reingold, A. L., et al. (2020) · BMJ · doi:10.1136/bmj.m1923 · Cited by 212
Thompson, H. A., Mousa, A., Dighe, A., Fu, H., Arnedo-Pena, A., Barrett, P., Bellido-Blasco, J., Bi, Q., Caputi, A., Chaw, L., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab100 · Cited by 209
A snapshot of the Covid-19 pandemic among pregnant women in France
Kayem, G., Lecarpentier, E., Deruelle, P., Bretelle, F., Azria, E., Blanc, J., Bohec, C., Bornes, M., Ceccaldi, P.-F., Chalet, Y., et al. (2020) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2020.101826 · Cited by 202
(2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-218310 · Cited by 198
Economic Burden of COVID-19: A Systematic Review
Richards, F., Kodjamanova, P., Chen, X., Li, N., Atanasov, P., Bennetts, L., Patterson, B. J., Yektashenas, B., Mesa-Frias, M., Tronczynski, K., et al. (2022) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s338225 · Cited by 191
Smoking changes adaptive immunity with persistent effects
Saint-André, V., Charbit, B., Biton, A., Rouilly, V., Possémé, C., Bertrand, A., Rotival, M., Bergstedt, J., Patin, E., Albert, M. L., et al. (2024) · Nature · doi:10.1038/s41586-023-06968-8 · Cited by 187
Chari, A., Samur, M. K., Martinez-Lopez, J., Cook, G., Biran, N., Yong, K., Hungria, V., Engelhardt, M., Gay, F., García Feria, A., et al. (2020) · Blood · doi:10.1182/blood.2020008150 · Cited by 187
Yang, W., Kandula, S., Huynh, M., Greene, S. K., Van Wye, G., Li, W., Chan, H. T., McGibbon, E., Yeung, A., Olson, D., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30769-6 · Cited by 185
Pouwels, K. B., House, T., Pritchard, E., Robotham, J. V., Birrell, P. J., Gelman, A., Vihta, K.-D., Bowers, N., Boreham, I., Thomas, H., et al. (2021) · The Lancet Public Health · doi:10.1016/s2468-2667(20)30282-6 · Cited by 176
Bunders, M. J., & Altfeld, M. (2020) · Immunity · doi:10.1016/j.immuni.2020.08.003 · Cited by 163
Matrajt, L., Eaton, J., Leung, T., Dimitrov, D., Schiffer, J. T., Swan, D. A., & Janes, H. (2021) · Nature Communications · doi:10.1038/s41467-021-23761-1 · Cited by 177
Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic
Abu-Raddad, L. J., Chemaitelly, H., Ayoub, H. H., Al Kanaani, Z., Al Khal, A., Al Kuwari, E., Butt, A. A., Coyle, P., Jeremijenko, A., Kaleeckal, A. H., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-85428-7 · Cited by 148
Insights into disparities observed with COVID‐19
Carethers, J. M. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13199 · Cited by 156
Roederer, T., Mollo, B., Vincent, C. C. N., Nikolay, B., Llosa, A. E., Nesbitt, R., Vanhomwegen, J., Rose, T., Anna, F., Torre, C., et al. (2021) · The Lancet Public Health · doi:10.1016/s2468-2667(21)00001-3 · Cited by 158
Rahmandad, H., Lim, T. Y., & Sterman, J. D. (2021) · System Dynamics Review · doi:10.1002/sdr.1673 · Cited by 152
Bojadzic, D., Alcazar, O., Chen, J., Chuang, S.-T., Capcha, J. M. C., Shehadeh, L. A., & Buchwald, P. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00070 · Cited by 154
Davies, N. G., Barnard, R. C., Jarvis, C. I., Russell, T. W., Semple, M. G., Jit, M., & Edmunds, W. J. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30984-1 · Cited by 142
Gérard, A. O., Romani, S., Fresse, A., Viard, D., Parassol, N., Granvuillemin, A., Chouchana, L., Rocher, F., & Drici, M. (2020) · Therapies · doi:10.1016/j.therap.2020.05.002 · Cited by 142
Recchi, E., Ferragina, E., Helmeid, E., Pauly, S., Safi, M., Sauger, N., & Schradie, J. (2020) · Research in Social Stratification and Mobility · doi:10.1016/j.rssm.2020.100508 · Cited by 137
Carrat, F., de Lamballerie, X. N., Rahib, D., Blanché, H., Lapidus, N., Artaud, F., Kab, S., Renuy, A., de Edelenyi, F. S., Meyer, L., et al. (2020) · International Journal of Epidemiology · doi:10.1093/ije/dyab110 · Cited by 157
Serodiagnostics for Severe Acute Respiratory Syndrome–Related Coronavirus 2: A Narrative Review
Cheng, M. P., Yansouni, C. P., Basta, N. E., Desjardins, M., Kanjilal, S., Paquette, K., Caya, C., Semret, M., Quach, C., Libman, M., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m20-2854 · Cited by 149
COVID-19: Rethinking the Lockdown Groupthink
Joffe, A. R. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.625778 · Cited by 180
COVID-19 human challenge studies: ethical issues
Jamrozik, E., & Selgelid, M. J. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30438-2 · Cited by 138
Kuter, B. J., Browne, S., Momplaisir, F. M., Feemster, K. A., Shen, A. K., Green-McKenzie, J., Faig, W. G., & Offit, P. A. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.02.029 · Cited by 132
Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave
Davis, J. T., Chinazzi, M., Perra, N., Mu, K., y Piontti, A. P., Ajelli, M., Dean, N. E., Gioannini, C., Litvinova, M., Merler, S., et al. (2021) · Nature · doi:10.1038/s41586-021-04130-w · Cited by 141
Ke, R., Romero-Severson, E. O., Sanche, S., & Hengartner, N. (2021) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2021.110621 · Cited by 145
Model-based estimation of transmissibility and reinfection of SARS-CoV-2 P.1 variant
Coutinho, R. M., Marquitti, F. M. D., Ferreira, L. S., Borges, M. E., Lopes, R., Canton, O., Portella, T. P., Poloni, S., Franco, C. F. J., Pluciński, M. M., et al. (2021) · Communications Medicine · doi:10.1038/s43856-021-00048-6 · Cited by 141
COVID-19 interstitial pneumonia: monitoring the clinical course in survivors
Raghu, G., & Wilson, K. C. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30349-0 · Cited by 128
Digital proximity tracing on empirical contact networks for pandemic control
(2021) · doi:10.1038/s41467-021-21809-w · Cited by 123
Sleep apnoea is a risk factor for severe COVID-19
Strausz, S. J., Kiiskinen, T., Broberg, M. E., Ruotsalainen, S., Koskela, J. T., Bachour, A., FinnGen, Palotie, A. V., Palotie, T., Ripatti, S., et al. (2021) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2020-000845 · Cited by 124
Quantifying Online News Media Coverage of the COVID-19 Pandemic: Text Mining Study and Resource
Krawczyk, K., Chełkowski, T., Mishra, S., Xifara, D., Gibert, B., Laydon, D. J., Flaxman, S. R., Mellan, T. A., Schwämmle, V., Röttger, R., et al. (2021) · Journal of Medical Internet Research · doi:10.2196/28253 · Cited by 148
COVID-19, Virology and Geroscience: A Perspective
Vellas, C., Delobel, P., Barreto, P. D. S., & Izopet, J. (2020) · The journal of nutrition health & aging · doi:10.1007/s12603-020-1416-2 · Cited by 139
Human mobility and COVID-19 initial dynamics
Iacus, S. M., Santamaria, C., Sermi, F., Spyratos, S., Tarchi, D., & Vespe, M. (2020) · Nonlinear Dynamics · doi:10.1007/s11071-020-05854-6 · Cited by 121
Gaudart, J., Landier, J., Huiart, L., Legendre, E., Lehot, L., Bendiane, M., Chiche, L., Petitjean, A., Mosnier, É., Kirakoya‐Samadoulougou, F., et al. (2021) · The Lancet Public Health · doi:10.1016/s2468-2667(21)00006-2 · Cited by 116
Predicted COVID-19 fatality rates based on age, sex, comorbidities and health system capacity
Ghisolfi, S., Almås, I., Sandefur, J., von Carnap, T., Heitner, J., & Bold, T. (2020) · BMJ Global Health · doi:10.1136/bmjgh-2020-003094 · Cited by 116
Ghram, A., Briki, W., Mansoor, H., Al-Mohannadi, A. S., Lavie, C. J., & Chamari, K. (2020) · Postgraduate Medicine · doi:10.1080/00325481.2020.1860394 · Cited by 133
Research perspectives on animal health in the era of artificial intelligence
Ezanno, P., Picault, S., Beaunée, G., Bailly, X., Muñoz, F., Duboz, R., Monod, H., & Guégan, J. (2021) · Veterinary Research · doi:10.1186/s13567-021-00902-4 · Cited by 147
Using Early Data to Estimate the Actual Infection Fatality Ratio from COVID-19 in France
Roques, L., Klein, E. K., Papaix, J. J., Sar, A., & Soubeyrand, S. (2020) · Biology · doi:10.3390/biology9050097 · Cited by 119
Barrat, A., Cattuto, C., Kivelä, M., Lehmann, S., & Saramäki, J. (2021) · Journal of The Royal Society Interface · doi:10.1098/rsif.2020.1000 · Cited by 130
Insights into household transmission of SARS-CoV-2 from a population-based serological survey
Bi, Q., Lessler, J., Eckerle, I., Lauer, S. A., Kaiser, L., Vuilleumier, N., Cummings, D. A. T., Flahault, A., Petrovic, D., Guessous, I., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23733-5 · Cited by 109
Self-citationSerologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France
Fafi-Kremer, S., Bruel, T., Madec, Y., Grant, R., Tondeur, L., Grzelak, L., Staropoli, I., Anna, F., Souque, P., Fernandes-Pellerin, S., et al. (2020) · eBioMedicine · doi:10.1016/j.ebiom.2020.102915 · Cited by 108
Self-citationVariation in SARS-CoV-2 outbreaks across sub-Saharan Africa
Rice, B. L., Annapragada, A. V., Baker, R. E., Bruijning, M., Dotse‐Gborgbortsi, W., Mensah, K., Miller, I. F., Motaze, N. V., Raherinandrasana, A. H., Rajeev, M., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01234-8 · Cited by 106
Hippich, M., Holthaus, L., Assfalg, R., Zapardiel‐Gonzalo, J., Kapfelsperger, H., Heigermoser, M., Haupt, F., Ewald, D., Welzhofer, T., Marcus, B. A., et al. (2020) · Med · doi:10.1016/j.medj.2020.10.003 · Cited by 113
Disease burden and clinical severity of the first pandemic wave of COVID-19 in Wuhan, China
Yang, J., Chen, X., Deng, X., Chen, Z., Gong, H., Yan, H., Wu, Q., Shi, H., Lai, S., Ajelli, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19238-2 · Cited by 114
COVID-19 Vaccine Hesitancy among French People Living with HIV
Vallée, A., Fourn, E., Majerholc, C., Touche, P., & Zucman, D. (2021) · Vaccines · doi:10.3390/vaccines9040302 · Cited by 109
Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
Zsichla, L., & Müller, V. (2023) · Viruses · doi:10.3390/v15010175 · Cited by 138
Jamrozik, E., Littler, K., Bull, S., Emerson, C., Kang, G., Kapulu, M. C., Rey, E., Saénz, C., Shah, S. K., Smith, P. G., et al. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.10.075 · Cited by 109
Modelling safe protocols for reopening schools during the COVID-19 pandemic in France
Domenico, L. D., Pullano, G., Sabbatini, C. E., Boëlle, P., & Colizza, V. (2021) · Nature Communications · doi:10.1038/s41467-021-21249-6 · Cited by 126
Bojadzic, D., Alcazar, O., & Buchwald, P. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.600372 · Cited by 113
Theoretical Framework for Retrospective Studies of the Effectiveness of SARS-CoV-2 Vaccines
Lewnard, J. A., Patel, M. M., Jewell, N. P., Verani, J. R., Kobayashi, M., Tenforde, M. W., Dean, N. E., Cowling, B. J., & Lopman, B. A. (2021) · Epidemiology · doi:10.1097/ede.0000000000001366 · Cited by 103
COVID-19 Among Patients With Multiple Sclerosis: A Systematic Review
Barzegar, M., Mirmosayyeb, O., Gajarzadeh, M., Afshari-Safavi, A., Nehzat, N., Vaheb, S., Shaygannejad, V., & Maghzi, A. (2021) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000001001 · Cited by 102
(2021) · doi:10.1016/j.vaccine.2021.04.002 · Cited by 101
Metadata
- Authors
- Salje, H., Tran Kiem, C., Lefrancq, N., Courtejoie, N., Bosetti, P., Paireau, J., Andronico, A., Hozé, N., Richet, J., Dubost, C.-L., Le Strat, Y., Lessler, J., Levy-Bruhl, D., Fontanet, A., Opatowski, L., Boelle, P.-Y., & Cauchemez, S.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Mathematical Modelling of Infectious Diseases Unit, Institut Pasteur, UMR2000, CNRS, Paris, France.
- Ministère des Solidarités et de la Santé (FR)
- Santé Publique France, French National Public Health Agency, Saint-Maurice, France.
- Johns Hopkins University (US)
- Conservatoire National des Arts et Métiers (FR)
- Inserm (FR)
- Institut Pierre Louis d’Epidémiologie et de Santé Publique, Sorbonne Université, INSERM, Paris, France.
- Corresponding author
- Cauchemez, Simon
- ORCID
- Venue
- Science
- Published
- 2020-07-10
- Volume
- 369
- Issue
- 6500
- Pages
- 208-211
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC7223792
- OpenAlex
- W3025090814
- Cited by
- 1,038
- References
- 30
- Citations by year
- 2026: 15 · 2025: 29 · 2024: 50 · 2023: 90 · 2022: 171 · 2021: 378 · 2020: 303
- FWCI
- 37.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Science (publishedVersion, cc-by)
- medRxiv (acceptedVersion, cc-by-nd)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by-nc-nd)
- HAL (submittedVersion, cc-by-nc)
- Funders
- H2020 European Research Council (804744)
- ANR (ANR-10-LABX-62-IBEID)
- INCEPTION (PIA/ANR-16-CONV-0005)
- Santé Publique France
- European Union RECOVER
- University of Cambridge COVID-19 Rapid Response Grant
- Topics
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS-CoV-2, COVID-19 pandemic, hospitalization rates, mortality rates, lockdown, reproduction number, herd immunity, age and sex differences, intensive care, second wave, France
- MeSH terms
- COVID-19, Adolescent, Adult, Aged, Aged, 80 and over, Critical Care, Female, France, Hospitalization, Humans, Immunity, Male, Middle Aged, Pneumonia, Viral, Quarantine, Cost of Illness, Coronavirus Infections, Severe acute respiratory syndrome-related coronavirus, Young Adult, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.